Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
OSCR Catalyst Timeline
Dated clinical, regulatory and corporate events for Oscar Health, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for Oscar Health, Inc.
Event history 1
Past FDA Catalysts and PDUFA Decisions
How OSCR actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
No drug pipeline
Oscar Health, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every OSCR program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WITTMAN VANESSA AMESDirector | Sell | -25,000 112,121 held | $32.24 | 09/18/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in OSCR
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PFM HEALTH SCIENCES, LP | 1.5 % (15.4 %) | 15.41 M | 499.84 K | -3.7% ( -19.18 K) |
Ownership Trends
OSCR Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-27 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How OSCR ranks across every disease it competes in
OSCR News
Hy-Vee Health with Oscar Expands Across Iowa, Into Kansas City and Omaha for 2027 Open Enrollment
Hy-Vee Health with Oscar is expanding its services across Iowa and into Kansas City and Omaha for the 2027 Open Enrollment period. Starting November 1, 2026, individuals can enroll through HealthCare.gov, benefiting from affordable healthcare options, including $0 primary care visits. The plan offers access to numerous healthcare providers and a rewards program for members.
Read more →Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
Oscar Health announced new health plans for Florida residents for the 2027 Open Enrollment. The RetireEase plan aims to support early retirees with affordable coverage options. Additional offerings include personalized health plans and partnerships with major healthcare providers, enhancing access to care. Enrollment begins on November 1, 2026.
Read more →Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
Oscar Health announced new health plan options for Texas individuals and families for the 2027 Open Enrollment. The new RetireEase plan targets early retirees, offering affordable healthcare solutions. Additional features include support for Spanish-speaking members and partnerships for supplemental coverage. Open Enrollment begins on November 1, 2026, with coverage starting January 1, 2027.
Read more →Oscar Health Expands its Board of Directors with Technology, Healthcare and Product Innovators to Advance Consumer Healthcare
Oscar Health announced the addition of Tomer Cohen, Eric Larsen, and Rajat Taneja to its Board of Directors, effective November 13, 2026. These appointments aim to enhance Oscar's consumer healthcare offerings and technology platforms. CEO Mark Bertolini emphasized their commitment to innovation and improving the healthcare experience for consumers.
Read more →Oscar Grows Across Ohio to Serve Nearly the Entire State for 2027 Open Enrollment
Oscar Health announced its expansion across Ohio, now serving 73 of 88 counties for the 2027 Open Enrollment. The insurer is entering 33 new counties, including Akron and Toledo, to provide affordable health plans. Oscar's offerings include various coverage options and tailored plans for different life stages, enhancing accessibility for residents.
Read more →Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook
Oscar Health reported its third quarter 2026 financial results, showing total revenue of approximately $5.1 billion, up from $3.0 billion in Q3 2025. The company raised its full-year revenue outlook to between $19.0 billion and $19.3 billion. CEO Mark Bertolini emphasized Oscar's growth strategy and strong market positioning. The medical loss ratio improved to 84.0%, reflecting better pricing strategies.
Read more →Oscar Introduces a New Wave of Consumer Health Products
Oscar Health, Inc. has launched its 2027 health insurance lineup, expanding to 713 counties across 21 states. The new offerings include RetireEase, a plan for early retirees transitioning to Medicare, and a range of health plans that provide significant savings. Oscar also introduces supplemental options and rewards for healthy actions.
Read more →Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call
Oscar Health, Inc. will announce its third quarter 2026 financial results on November 5, 2026. Management will hold a conference call at 8:00 AM (ET) to discuss these results. A live audio webcast will be accessible, and a replay will be available for 90 days afterward.
Read more →Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners
Oscar Health announced that Thrive Capital distributed approximately 6.3 million Class A shares to its limited partners on September 18, 2026. This distribution marks a return of capital after a 14-year holding period. Joshua Kushner, founder of Thrive Capital, reaffirmed his commitment to Oscar Health's long-term growth and has no plans to sell his shares.
Read more →Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook
Oscar Health, Inc. reported record financial results for the first half of 2026, with total revenue reaching approximately $9.5 billion, a significant increase from $5.9 billion in the previous year. The company also improved its medical loss ratio to 75.0% and raised its full-year guidance, reflecting strong operational performance. CEO Mark Bertolini emphasized the company's strategic positioning for long-term growth.
Read more →Oscar Health, Inc. to Host 2026 Investor Day
Oscar Health, Inc. will hold its 2026 Investor Day on September 16, 2026. The event will feature discussions on the company's corporate strategy and long-term financial targets. A live webcast will be available, and the presentation will be archived for 90 days on the investor relations website.
Read more →Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call
Oscar Health, Inc. will announce its second quarter 2026 financial results on August 6, 2026. A conference call will follow at 8:00 AM (ET) to discuss these results. The call will be archived for 90 days on the company's investor relations website.
Read more →Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance
Oscar Health reported Q1 2026 revenue of $4.6 billion, up from $3.0 billion in the prior year. Net income reached $679 million, driven by higher membership and disciplined pricing. The medical loss ratio improved to 70.5% from 75.4%. The company reaffirmed its full-year 2026 guidance.
Read more →Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board
Oscar Health, Inc. appointed Siddhartha Sankaran as the new Chair of the Board, effective June 4, 2026. He succeeds Jeffery Boyd, who has served since February 2021. Sankaran brings over 20 years of experience in the insurance industry and is expected to guide Oscar through its next growth phase.
Read more →Meet Lucie. A New Way to Shop for Healthcare.
The article introduces a new healthcare shopping platform named Lucie. It emphasizes the platform's focus on privacy and protection for users. However, specific details about its features or benefits are not provided.
Read more →Oscar Health, Inc. 2026 First Quarter Earnings Conference Call
Oscar Health, Inc. will announce its first quarter 2026 financial results on May 6, 2026. A conference call will follow at 8:00 AM (ET) to discuss these results. The call will also be archived for 90 days on Oscar's investor relations website. Oscar serves around 3.4 million members.
Read more →Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call
Oscar Health, Inc. will announce its fourth quarter and full year 2025 financial results on February 10, 2026. A conference call will follow at 8:00 AM ET to discuss these results. The call will be archived for 90 days on the company's investor relations website. Oscar Health continues to focus on technology-driven healthcare solutions.
Read more →Oscar Health Prices Upsized
Oscar Health, Inc. has priced its upsized offering of $355 million in convertible senior subordinated notes, intended to bolster long-term growth and market adoption. The offering's net proceeds, estimated at approximately $342.5 million, will be used for corporate purposes and strategic initiatives. Notably, Oscar aims to enhance consumer healthcare experiences while pursuing opportunities related to premium tax credits.
Read more →Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
Oscar Health, Inc. has announced a proposed offering of $350 million in convertible senior subordinated notes, intending to use the proceeds for general corporate purposes and strategic growth initiatives. This initiative aims to enhance consumer healthcare experiences through advancements in AI and potentially extend premium tax credits. The company also plans to settle conversions with cash or shares of its common stock. The notes will be unsecured and subject to various conditions that could affect their performance and the company’s stock price.
Read more →Oscar Health, Inc. ir.hioscar.com News Release Oscar Health, Inc. Announces that Mark Bertolini s Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar
Oscar Health, Inc. announced a Stock Purchase Agreement where Deerfield Management and the Anahata Foundation will purchase shares of its Common Stock. Deerfield is to acquire 3 million shares while Anahata will buy 2 million shares. The transactions are scheduled to close around November 22, 2023, pending customary conditions. Oscar is not a party to these agreements but benefits from the endorsement and financial backing of these investors.
Read more →